Sheehan KA, Ke Y, Wolska BM, Solaro RJ. Expression of active p21-activated kinase-1 induces Ca 2ϩ -flux modification with altered regulatory protein phosphorylation in cardiac myocytes.
2ϩ content nor fractional release was different in CA-Pak1 myocytes compared with controls. Isoproterenol application revealed a significantly blunted increase in [Ca 2ϩ ]i transient amplitude, as well as a slowed rate of [Ca 2ϩ ]i decay, increased SR Ca 2ϩ content, and increased cell shortening, in CA-Pak1 myocytes. We found no significant change in phospholamban phosphorylation at Ser 16 or Thr 17 in CA-Pak1 myocytes. Analysis of cardiac troponin I revealed a significant reduction in phosphorylated species that are primarily attributable to Ser 23/24 in CA-Pak1 myocytes. Nonstimulated, spontaneous SR Ca 2ϩ release sparks were significantly smaller in amplitude in CA-Pak1 than LacZ myocytes. Propagation of spontaneous Ca 2ϩ waves resulting from SR Ca 2ϩ overload was significantly slower in CA-Pak1 myocytes. Our data indicate that CA-Pak1 expression has significant effects on ventricular myocyte contractility through altered myofilament Ca 2ϩ sensitivity and modification of the [Ca 2ϩ ]i transient.
cardiac relaxation; phosphatase; sarcoplasmic reticulum A SPECIALIZATION OF CARDIAC muscle is that contraction and relaxation dynamics rely strongly on the rapid alteration of regulatory protein phosphorylation state, much more so than in the case of skeletal muscle. These posttranslational modifications affect the sensitivity of the myofilaments to Ca 2ϩ activation, cross-bridge cycling rate (15, 27) , and fluxes of Ca 2ϩ to and from the myofilament binding sites, thus enabling the heart to respond rapidly to changing systemic demands for cardiac output. The most prominent mechanism inducing augmentation of contraction/relaxation dynamics is ␤-adrenergic signaling primarily through the cAMP-dependent kinase (PKA)-mediated phosphorylation of myofilament and Ca 2ϩ flux-regulatory proteins, although additional phosphorylations may occur at other sites through the action of PKC or Ca 2ϩ / calmodulin-dependent protein kinase II (CamKII).
In contrast to the involvement of kinase activity in modulation of cardiac contractility, the mechanisms signaling dephosphorylation processes in the return to basal function are not as well defined. The major cardiac phosphatases, protein phosphatase 1 and protein phosphatase 2A (PP2A), are expressed widely in the heart (38, 47) and are known to associate with regulatory proteins controlling sarcomeric function and Ca 2ϩ fluxes (30, 40) . Cellular agents such as adenosine and acetylcholine have been identified as antiadrenergic, with associated activation of phosphatase activity (33, 48) , but intermediates and localization in the signaling cascade are poorly understood. Although phosphatases such as PP2A are ubiquitously expressed, they are known to be targeted to particular locations by association with different regulatory B subunits of the holoenzyme (2, 17, 20) . There is also a growing body of evidence suggesting that PP2A may be locally regulated through association with an intermediate protein (for review see Ref. 23) .
In experiments reported here, we have focused on p21-activated kinase-1 (Pak1), which we recently identified as a potentially important intermediate in the PP2A signaling cascade. Pak1 is a serine-threonine kinase that is involved in actin cytoskeletal remodeling and activated by the small monomeric GTPases Rac1 and cdc42 (12, 43) . Pak1 forms a complex with PP2A in neuronal cells, where it provides localization and functional specificity of the phosphatase (63) . In our previous studies, we reported that endogenous Pak1 colocalizes with PP2A in cardiac myocytes at the level of the Z disk and induces its dephosphorylation at Tyr 307 , indicative of activation of the phosphatase (26) . Adult rat ventricular myocytes expressing constitutively active Pak1 (CA-Pak1) exhibited a significantly reduced level of cardiac troponin I (cTnI) and myosin binding protein C phosphorylation, as assessed by incorporation of 32 P. This was concurrent with a leftward shift in the Ca 2ϩ -tension relationship recorded in isolated detergent-extracted myocytes and a higher developed maximal tension (26) . These data demonstrate that Pak1 is a novel activator of PP2A in the dynamic regulation of myofilament protein phosphorylation and contractile function of the heart. In the present study, we extend our hypothesis and propose that Pak1-mediated control of contractility goes beyond the myofilaments to include regulation of intracellular 85-23, revised 1985) and approved by the Institutional Animal Review Board of the University of Illinois at Chicago. Cardiac ventricular myocytes were isolated from the hearts of adult male 2-to 3-mo-old Sprague-Dawley rats by a collagenase perfusion method, as previously described (65) . For cell culture, freshly isolated ventricular myocytes in a standard Tyrode solution [in mM: 137 NaCl, 5 KCl, 10 HEPES, 10 dextrose, 1 MgCl 2, and 1 CaCl2 (pH 7.4)] were allowed to settle onto glass coverslips (Fisher Scientific, Pittsburgh, PA) previously coated with laminin (20 g/ml; Sigma-Aldrich, St. Louis, MO). The cells were cultured for 1 h in creatine-carnitine-taurine medium (Medium 199, Cellgro, Herndon, VA) for cell attachment. The medium was changed, and the cells were cultured overnight in an atmosphere of 5% CO 2. Cells were infected with recombinant adenoviruses expressing CA-Pak1 or LacZ at the time the medium was changed. Expression of CA-Pak1 was determined by Western blotting of whole cell lysates with hemagglutinin (HA)-specific (Sigma-Aldrich) and Pak1-specific (Cell Signaling) antibodies (Fig. 1) .
AdPak1 construction, viral amplification, and plaque assays. Using the PCR method to tag the human Pak1 cDNA with an HA epitope (YPYDVPDYA) at the NH 2-terminal region and next to the translational initiation codon, we prepared recombinant adenovirus that expressed CA-Pak1 or dominant-negative kinase Pak1 (DN-Pak1). Thr 423 was mutated to glutamic acid to convert the Pak1 protein to a constitutively active form (42) . The dominant-negative kinase form was made by mutation of Lys 299 to arginine (4). The cDNA was then cloned into the shuttle vector pAdCMV to obtain pAdCMVPak1. AdPak was made by homologous recombination between pAdCMVPak1 and the viral backbone DNA DL7001 (54) . The lysate of virus amplified from a clone was used to infect 911 cells cultured in 100-mm dishes. The lysate from these dishes was subsequently used to infect confluent cells in five to ten 150-mm dishes. Cells were harvested at maturity, ϳ28 -35 h after infection. The lysates were applied at the top of a discontinuous CsCl gradient and centrifuged at 20,000 g for 2 h. The lower of two bands formed during centrifugation contained mature viral particles, which were harvested using a syringe and again applied to the top of a CsCl gradient and centrifuged at 20,000 g for 12 h. The particles on the lower band were again harvested using a syringe and separated from the CsCl gradient by dialysis against HEPES-buffered saline. Virus in the dialysis unit was used directly or mixed with storage buffer and stored at Ϫ80°C. The viral titer (plaque-forming units/ml) and multiplicity of infection (MOI) were determined by standard techniques.
[Ca 2ϩ ]i imaging. Single, intact adult rat ventricular myocytes were loaded with the Ca 2ϩ indicator fluo 4 or fura 2 by exposure for 20 min at room temperature to a standard Tyrode solution containing 10 M fluo 4-AM (Invitrogen, Carlsbad, CA) or 3 M fura 2-AM (Invitrogen) made from a DMSO stock solution. Deesterification of the indicator was accomplished by a Ն15-min wash cycle in dye-free solution. Coverslips containing single myocytes were mounted on the stage of an inverted Nikon microscope and continuously perfused with a solution containing (in mM) 137 NaCl, 5 KCl, 10 HEPES, 1 MgCl 2, and 1 CaCl2 (pH 7.4). In some experiments, 100 nM isoproterenol (Iso) was added to the perfusate. All experiments were performed under steady-state conditions. Single cells were field stimulated by application of a 4-ms suprathreshold square voltage pulse at 0.5 Hz to the cell bath through parallel platinum electrodes. In experiments using the confocal microscope and fluo 4, the laser scanning line was set at a central focal plane and oriented parallel to the longitudinal axis of the cell, with care taken to avoid the nucleus. The indicator was excited with the 488-nm line of an argon ion laser attached to the microscope via a confocal laser-scanning unit (Bio-Rad Radiance 2100, Carl Zeiss, Thornwood, NY) equipped with a ϫ60 water immersion objective. Emitted fluo 4 fluorescence was measured at Ͼ515-nm wavelengths. Images were acquired in the line-scan mode at a scanning rate of 2 ms per line. Fluorescence images were calibrated for [Ca 2ϩ ]i according to the following formula (5)
where R is fluorescence (F) normalized to resting fluorescence (F0; i.e., R ϭ F/F0), Kd is the dissociation constant for the Ca 2ϩ -dye complex [Kd for fluo 4 was 1.1 M (60)], and [Ca 2ϩ ]rest was 100 nM (22, 32) . All experiments were performed at room temperature (i.e., 26 -28°C). Acquired images were stored for later analysis using Image J (National Institutes of Health, Baltimore, MD) and Igor (Wavemetrics, Eugene, OR) software. The time constants of [Ca 2ϩ ]i transient decay (decay, ms) were evaluated by a monoexponential fit to the declining phase of the [Ca 2ϩ ]i transient. Individual Ca 2ϩ spark characteristics were determined from the line-scan images with use of an automated spark detection algorithm (10) . Images were processed at a level that detected release events but excluded background noise, as determined by inspection of the images. Values for amplitude (F/F 0), full-width at half-maximum amplitude (m), and duration at half-maximum amplitude (ms) were tabulated from the algorithm output. F0 is the fluorescence (F) recorded under steady-state conditions at the beginning of each experiment. Ca 2ϩ spark frequencies are expressed as the number of sparks observed per second and per 100 m of scanned distance (sparks ⅐ s Ϫ1 ⅐ 100 m Ϫ1 ). In experiments where wide-field [Ca 2ϩ ]i transients and unloaded cell shortening were recorded simultaneously, coverslips containing single myocytes loaded with fura 2 were mounted on the stage of an inverted Nikon microscope and continuously perfused with the normal Tyrode solution described above. Cells were field stimulated through parallel platinum electrodes with 4-ms suprathreshold square pulses at a frequency of 0.5 Hz. Fura 2 fluorescence and shortening of cells were recorded simultaneously, as previously described (65, 66) . Fura 2-loaded myocytes were alternately excited at 340-and 380-nm wavelengths. Emitted fluorescence was measured at a wavelength of 505 nm by a photomultiplier tube at 6.67-ms intervals. Background fluorescence was recorded daily by measurement of the autofluorescence of myocytes at both excitation wavelengths in the absence of dye loading, stored in the acquisition software (Felix 32, Photon Technology International, Birmingham, NJ), and used for subtraction in subsequent recordings. Fluorescence signals are reported as the background-subtracted ratio of fura 2 fluorescence at 340 nm to that at 380 nm (340/380 ratio). The sarcoplasmic reticulum (SR) Ca 2ϩ content of the myocytes was assessed by rapid application of 10 mM caffeine to the cellular perfusate immediately after cessation of field stimulation. Field-stimulated Ca 2ϩ release was expressed as a fraction of available SR Ca 2ϩ according to the modified formula (1, 57) fractional Ca 2ϩ release ϭ ͑peak twitch ͓Ca
Cell shortening was recorded by illumination of the myocytes with red transmitted light (Ͼ600 nm). The cell image was collected through the microscope objective lens and transmitted to the multiimage module, where it was separated from the fluorescence signal by a 580-nm dichroic mirror. Output from the camera was split and sent to a chart recorder and to a video-edge detector (Crescent Electronics, Sandy, UT) (59) . The cell length and fluorescent signals were recorded simultaneously on an acquisition computer for later analysis offline.
Preparation of myocytes for protein phosphorylation Western blotting. Freshly isolated adult rat myocytes were plated onto 60-mm tissue culture plates coated with laminin, infected with virus, and cultured overnight (see above). After the cells were treated with Iso or vehicle, the reactions were terminated with a modified radioimmunoassay precipitation buffer (RIPA, Upstate, Charlottesville, VA). SDS-PAGE was performed using a 10% polyacrylamide gel. After electrophoresis, proteins were transferred to a polyvinylidene difluoride membrane (Bio-Rad) and incubated overnight with the primary antibody [phosphorylated phospholamban (p-PLB; Upstate) and phosphorylated cTnI (Cell Signaling, Beverly, MA)] in Tris-buffered saline (TBS) and 5% nonfat dry milk with shaking at 4°C. The membrane was incubated in secondary antibody conjugated to horseradish peroxidase for 1.5 h at room temperature (23°C) and developed by enhanced chemiluminescence. Films were scanned and quantified by densitometric analysis using Image J software.
Nonequilibrium isoelectric focusing. Myocytes were plated onto 60-mm tissue culture plates coated with laminin (see above), and cultured overnight after infection with CA-Pak1 or Ad-LacZ. The cultured myocytes were treated with 100 nM Iso or vehicle and harvested in TBS [in mM: 140 NaCl and 20 Tris (pH 7.4)]. Total protein content was determined using the RC DC protein assay (Bio-Rad). The isoelectric focusing gel contained 6 M urea, 5% acrylamide, 3% cross-linker (Bio-Rad), 2% Triton X-100, 0.4% ampholyte with pH 3-10, and 1.6% ampholyte with pH Ͼ9 (Amersham). Sample loading buffer contained 8 M urea, 2 M thiourea, 10 mM EDTA (pH 8.0), 1% ampholyte with pH 3-10, and 2 mM TATA binding protein. The presence of urea and EDTA facilitates the dissociation of TnI from other troponin components. The cathode buffer was placed in the upper reservoir of a Criterion gel box (10 mM H 3PO4) and the anode buffer in the lower reservoir (100 mM NaOH), and the electrodes were reversed. The gels were run at 100 V for 20 min, 200 V for 20 min, 400 V for 20 min, and 500 V for 25 min. After isoelectric focusing, the gels were transferred to 0.2-m nitrocellulose membranes in 10 mM 3-cyclohexylamino-1-propanesulfonic acid (CAPS) and 10% methanol (pH 11.0) at 20 V for 3 h at 0°C. Membranes were blocked with 5% nonfat dry milk in TBS-0.1% Tween 20 for 1 h at 4°C before incubation with cTnI monoclonal antibody at 1:4,000 dilution (clone C5, Fitzgerald Industries). Horseradish peroxidase-conjugated secondary antibodies (Sigma Chemical) were used at 1:20,000 dilution, detected using ECL Plus (Pierce), and imaged using Image FX laser (Bio-Rad). Blots were quantified using Image J, and phosphorylation was expressed as follows: fraction phosphorylated ϭ TnI (phosphorylated)/TnI (phosphorylated ϩ unphosphorylated).
Data presentation and statistical analysis.
Values are means Ϯ SE for the indicated number of cells. Statistical significance was evaluated using Student's t-test. In experiments where more than two groups were compared, statistical significance was evaluated using a one-way ANOVA. Statistical significance of spark frequency was evaluated using a nonparametric Mann-Whitney U test.
RESULTS

Expression of Pak1 in adult rat ventricular myocytes alters intracellular Ca
2ϩ fluxes. Initially, we established the levels of CA-Pak1 protein expression in cultured adult rat ventricular myocytes. Figure 1 shows Western blots for the HA tag and for total Pak1 expression in myocytes infected with the adenoviral CA-Pak1 construct at 0, 50, 100, and 200 MOI. Expression was substantial for each MOI. All further experiments were conducted on cultured cells infected at 100 MOI. We previously established the pattern of localization of endogenous Pak1 and expressed CA-Pak1 by immunohistochemistry in rat ventricular myocytes. Endogenous Pak1 staining revealed localization in a striated pattern at the level of the Z disk, as well as localization to the cell and nuclear membranes. Adenoviralmediated expression of CA-Pak1 showed no striations, indicating that active Pak1 has a cytosolic localization (26) .
To test our hypothesis that Pak1 activity alters the regulation of contractility, in part through its action on cellular Ca fluxes (data not shown). As a further test that the changes we observed were due to the kinase activity of CA-Pak1, we constructed DN-Pak1 virus by substituting Lys 299 with arginine (4) and expressed it in cardiac myocytes by the same method used to express CA-Pak1 and LacZ. We then examined the [Ca 2ϩ ] i transient parameters using field stimulation, fluo 4, and laser-scanning confocal microscopy. We found no differences in field-stimulated peak [Ca 2ϩ ] i amplitude, rate of Ca The slower rate of [Ca 2ϩ ] i decay in CA-Pak1-expressing myocytes (Fig. 2) suggests that the reuptake of Ca 2ϩ to the SR may be impaired, which in turn would provide less Ca 2ϩ for release. To examine the SR Ca 2ϩ content, we used the simultaneous measurement of wide-field fluorescence with the ratiometric Ca 2ϩ indicator fura 2 and video-edge detection of unloaded cell shortening. This allowed us to evaluate the intracellular Ca 2ϩ transient and, additionally, facilitated the determination of the degree and kinetics of cell shortening. All field stimulation experiments were performed at 0.5 Hz.
We found that there was no difference in the diastolic levels of fura 2 fluorescence ratio between CA-Pak1-and LacZexpressing cells (340/380 ratio ϭ 0.24 Ϯ 0.02 and 0.26 Ϯ 0.02, respectively, not significant), indicating that Pak1 activity does not significantly alter resting cellular Ca 2ϩ under normal conditions. We tested the SR Ca 2ϩ content by rapidly applying 10 mM caffeine to the cells immediately after ceasing field stimulation. Figure 3A shows that the average peak fura 2 ratio (340/380 ratio) for a normal field-stimulated twitch was 0.48 Ϯ 0.02 in LacZ cells (n ϭ 10 cells from 6 hearts) and 0.45 Ϯ 0.02 in CA-Pak1 cells (n ϭ 11 cells from 6 hearts, not significant). Perfusion of the cells with 100 nM Iso caused a significant increase in the field-stimulated LacZ Ca 2ϩ peak compared with control (340/380 ratio ϭ 0.71 Ϯ 0.05, P Ͻ 0.01). In CA-Pak1 cells, Iso also increased the field-stimulated peak Ca 2ϩ compared with control (340/380 ratio ϭ 0.58 Ϯ 0.03, P Ͻ 0.05), but this value was significantly blunted compared with the LacZ value (P ϭ 0.01), confirming the fluo 4 results.
The caffeine-induced peaks ( Figure 4D summarizes the time to peak shortening for LacZ and CA-Pak1 myocytes without and with Iso. The time to peak shortening was significantly faster in CA-Pak1 than LacZ myocytes (140.0 Ϯ 11.3 vs. 172.1 Ϯ 10.2 ms, P Ͻ 0.05). Application of Iso significantly reduced the time to peak contraction for LacZ and CA-Pak1 cells (119.1 Ϯ 4.1 and 93.5 Ϯ 7.7 ms, respectively) compared with their own controls. Although the time to peak shortening was faster for CA-Pak1 than LacZ myocytes in the presence of Iso, this difference did not reach significance. Figure 4E summarizes the time to 90% relengthening for the same groups of myocytes. The time to 90% relengthening was significantly slower in CA-Pak1 than LacZ myocytes (427.2 Ϯ 48.9 vs. 328.5 Ϯ 23.2 ms, P Ͻ 0.05). After treatment with Iso, the time for relengthening was significantly faster in LacZ and CA-Pak1 myocytes (165.9 Ϯ 8.7 and 220 Ϯ 23.6 ms, respectively). Similar to the time to peak shortening, the time for relengthening was longer in CA-Pak1 than LacZ myocytes, although the difference did not reach significance. These data demonstrate that Pak1 kinase activity modifies the processes regulating intracellular Ca 2ϩ fluxes independently of its effects on the myofilament. These distinct, separable effects of Pak1 on the two major processes regulating beat-to-beat contractile strength are evidence of the dual nature of Pak1 in the integrated regulation of cardiac contractility.
To further evaluate the effects of CA-Pak1 on intracellular Ca 2ϩ , we used confocal microscopy to examine Ca 2ϩ sparks. In cardiac myocytes, the electrically stimulated [Ca 2ϩ ] i transient is composed of elementary events of SR Ca 2ϩ release, or Ca 2ϩ sparks (9, 36) , that represent the opening of clusters of the SR Ca 2ϩ release channels, or ryanodine receptors (RyRs). These openings may be spontaneous, particularly in the case of We used Western blotting to determine the phosphorylation states of specific regulatory proteins involved in mediating After treatment with 100 nM Iso, PLB phosphorylation at Ser 16 was not significantly different between LacZ and CA-Pak1 cells (100 Ϯ 7 and 97 Ϯ 9%, not significant; Fig. 6B ). Levels of Thr 17 phosphorylation were not significantly different without Iso treatment (23 Ϯ 6% and 27 Ϯ 6% in LacZ and CA-Pak1, respectively) or after Iso treatment (71 Ϯ 4% and 80 Ϯ 5% in LacZ and CA-Pak1, respectively). The lack of a significant shift in PLB dephosphorylation in CA-Pak1 myocytes, particularly at Ser 16 in the presence of Iso, indicates that participation of Pak1 in dephosphorylation activity at this site is not sufficient to oppose the PKA-mediated increase in PLB phosphorylation and, thus, SR Ca 2ϩ uptake.
We used a novel nonequilibrium isoelectric focusing method developed in our laboratory (28, 56) to evaluate the cTnI phosphorylation states in LacZ and CA-Pak1 myocytes. This method has the advantage that the phosphorylation species of cTnI can be separated into bands representing the unphosphorylated protein as well as several additional phosphorylated sites. The phosphorylation states represented by each band are additive, as previously shown by Kobayashi et al. (28) and Scruggs et al. (56) , with each higher-migrating band also containing phosphorylated species from the lower bands. A representative blot of LacZ and CA-Pak1 whole cell lysates (Fig. 7A) illustrates the phosphorylation profile of cTnI without and with 100 nM Iso. We observed the same migration pattern of at least five distinct phosphorylated species of cTnI for LacZ and CA-Pak1. The lowest band, U, is the unphosphorylated cTnI protein. The next-higher band, P2, contains species phosphorylated at the Ser 23/24 sites, whereas the P4 band consists of species phosphorylated at other sites in addition to Ser 
DISCUSSION
Our data present novel evidence that CA-Pak1 expressed in single, isolated adult rat ventricular myocytes significantly changes the decay and peak characteristics of the [Ca 2ϩ ] i transient and that the peak changes are more pronounced after stimulation with Iso. We further establish that this shift in the processes controlling the delivery of Ca 2ϩ to the myofilaments is distinct from the changes in the myofilament contractile response.
In general, the mechanisms that modulate the phosphorylation state of cardiac contractile regulatory proteins depend on the dynamic balance of kinase activity with cellular phosphatase activity, although the dephosphorylation control mechanisms are not well understood (16, 29, 58, 62) . Pak1 has been identified as a component of a functional protein complex, along with PP2A in neuronal cells, where it is significant in the localized regulation of PP2A activity (63) . Previous evidence from this laboratory has established that CA-Pak1 expressed in adult rat ventricular myocytes is localized at the Z disk and facilitates the autodephosphorylation of PP2A at Tyr 307 (26) , signifying increased catalytic activity (7). Functionally, CA- 16 and Thr 17 and total PLB in whole cell lysates of myocytes (PLBm) expressing LacZ or CA-Pak1, with and without treatment with 100 nM Iso. B: phosphorylation of PLB at Ser 16 and Thr 17 as percentage of total phosphorylation. Phosphorylation at Ser 16 was not different between LacZ and CA-Pak1 myocytes: 5 Ϯ 2% and 5 Ϯ 2%, respectively, before Iso treatment and 100 Ϯ 7% and 97 Ϯ 9%, respectively, after Iso treatment (n ϭ 5 hearts). Values were normalized to results from Iso-treated LacZ myocytes. Similar results were obtained for Thr 17 phosphorylation as percentage of total phosphorylation: 23 Ϯ 6% and 27 Ϯ 6% for LacZ and CA-Pak1, respectively, before Iso and 71 Ϯ 5% and 80 Ϯ 5% for LacZ and CA-Pak1, respectively, after Iso (n ϭ 4 hearts). Values are means Ϯ SE.
Pak1 expression induced dephosphorylation of cTnI and myosin binding protein C, with a concurrent increase in the Ca 2ϩ sensitivity of tension development in detergent-extracted myocytes. The myofilament response and also the cellular Ca 2ϩ fluxes that supply activating Ca 2ϩ to the myofilaments are modulated by regulatory protein phosphorylation state and, thus, alter contractility. This leads to our present hypothesis that Pak1 catalytic activity regulates cardiac contractility through the integrated modification of intracellular Ca 2ϩ fluxes, as well as myofilament Ca 2ϩ sensitivity. We observed a change in the [Ca 2ϩ ] i characteristics consisting of a significantly slower rate of Ca 2ϩ decline in CA-Pak1-than LacZ-expressing controls, concurrent with longer time for cellular relengthening. The levels of PLB phosphorylation at Ser 16 and Thr 17 were not significantly different between CAPak1 and control myocytes, nor was cTnI phosphorylation at Ser 23/24 significantly different. There was no change in CAPak1 cell SR Ca 2ϩ content as assessed by caffeine, consistent with the lack of change in PLB phosphorylation. This indicates CA-Pak1 slows the intracellular Ca 2ϩ decay rate independently of PLB, although the exact mechanism remains to be determined. release, or Ca 2ϩ sparks, result from the opening of a cluster of RyRs (3) and summate to form the intracellular Ca 2ϩ release transient (6, 9) . We thus examined spontaneous Ca 2ϩ sparks in LacZ and CA-Pak1 myocytes to gain insight into RyR function. The frequency and amplitude of Ca 2ϩ sparks are determined in part by the SR Ca 2ϩ content (8, 37, 55) . We observed a significant reduction in the amplitude of spontaneous Ca 2ϩ sparks in CA-Pak1 compared with LacZ cells but no change in the frequency of occurrence. The lower amplitude may be in part due to the slight decrease in SR Ca 2ϩ content we observed (Fig. 3) , but we would also expect the spark frequency to be lower under these conditions. Alternatively, the lower spark amplitude in CA-Pak1 myocytes may suggest that the RyR channel P o may be lower, so that fewer RyRs are gating within a cluster. The spatial spread of the sparks was reduced, but the temporal duration was unchanged, suggesting that fewer channels opened but the kinetics of opening and closing were the same. The slower propagation velocity of spontaneous Ca 2ϩ waves indicates a resistance to activation of adjacent RyR clusters by cytosolic Ca 2ϩ in CA-Pak1 cells. Thus Pak1 activity may alter RyR2 gating via dephosphorylation by PP2A, but a full characterization is beyond the scope of this work.
Another potential target for Pak1 activity in the excitationcontraction coupling mechanism is the voltage-dependent Ltype Ca 2ϩ channel, or DHPR. This sarcolemmal ion channel forms a functional complex with a number of kinases, phosphatases, and anchoring proteins (for review see Ref. 24 23/24 . B: average density of bands normalized to total band density [56 Ϯ 6% and 60 Ϯ 4% for LacZ and CA-Pak1, respectively (U), 23 Ϯ 4% and 27 Ϯ 2% for LacZ and CA-Pak1, respectively (P2), and 22 Ϯ 3% and 13 Ϯ 5% for LacZ and CA-Pak1, respectively (P4), without Iso; 20 Ϯ 5% and 19 Ϯ 5% for LacZ and CA-Pak1, respectively (U), 36 Ϯ 1% and 28 Ϯ 3% for LacZ and CA-Pak1, respectively (P2), and 44 Ϯ 5% and 53 Ϯ 8% for LacZ and CA-Pak1, respectively (P4), with Iso]. Values are means Ϯ SE (n ϭ 4 hearts). *Statistically significant difference.
PP2A reduces both L-type Ca 2ϩ current (I Ca ) and the intracellular Ca 2ϩ transient (14) , although the activating mechanism of the phosphatase is unclear. A recent study from our laboratory (25) The simultaneous recording of unloaded cell shortening and fura 2 fluorescence enabled us to correlate the CA-Pak1-induced changes in the [Ca 2ϩ ] i transient with changes in the shortening characteristics. We found that the CA-Pak1 myocytes exhibit a greater Ca 2ϩ sensitivity of contraction (Fig. 4C ) as a result of myofilament modification, and, at the same time, the [Ca 2ϩ ] i transient is reduced because of changes in the excitation-contraction coupling process. We also showed a significantly faster time to peak shortening and slower time to 90% relengthening in CA-Pak1 myocytes. Although this difference did not reach significance in the presence of Iso, there was a trend toward a faster time of shortening and slower relengthening, which supports our hypothesis that Pak1 activity modifies excitation-contraction coupling separately from myofilament contractility.
In the present study, we have focused on PKA-mediated regulatory protein phosphorylation sites, but other groups of kinase pathways in the heart potentially involve Pak1. When activated by Ca 2ϩ -bound calmodulin, CaMKII phosphorylates a number of excitation-contraction coupling-related proteins (for review see Ref. 40) , including RyR2 at Ser 2809 , the same site as PKA, but it is uncertain whether this results in a higher or lower channel P o (33, 62) . I Ca is facilitated by CaMKII phosphorylation (18) . PLB is phosphorylated at Thr 17 by CamKII and plays a role in the regulation of frequencydependent acceleration of relaxation (FDAR) (52) , although other CaMKII-related processes appear to be involved (12) . There is recent evidence that CaMKII activity in FDAR may be influenced by kinase autophosphorylation and the activity of associated protein phosphatases (10) . Since Pak1 is known to associate with PP2A and modify its activity, there may be a role for Pak in FDAR. In the present study, we have shown that CA-Pak1 expression does not significantly alter the levels of Thr 17 phosphorylation of PLB, but time of relengthening is slower in CA-Pak1 than LacZ cells. The ability of CA-Pak1 to change relaxation rates suggests that it may have a further role in the regulation of FDAR.
The PKC family of kinases is also significant in the regulation of contractility, primarily through phosphorylation of myofilament regulatory proteins (17, 20, 48, 50, 51) , modifying the Ca 2ϩ sensitivity of force, and the cross-bridge cycling rate. Previous studies have indicated that cTnI can be phosphorylated at Ser 23/24 by PKC␤II, PKCε (27) , and PKC␦ (49) in vitro, thus participating in the regulation of contractility. A recent study from our laboratory has indicated that PKC forms a complex with Pak1 and PP2A, resulting in reduced threonine phosphorylation of cTnI and cTnT (65) . Thus Pak1 involvement in contractile regulation of the thin filament potentially involves PKC-mediated phosphorylation processes.
Our data provide significant novel evidence for the functional action of Pak1 in the integrated regulation of cardiac contractility through modification of intracellular Ca 2ϩ fluxes in intact ventricular myocytes, distinct from its effects on thin filament regulation. We propose that Pak1 is an important novel regulator of heart function that remains to be fully explored.
